Hepatitis C Therapy – Related Haematological Side Effects are Associated with Treatment Outcome / Hematološka Neželjena Dejstva Terapije Hepatitisa C Su Povezana Sa Ishodom Lecenja

Pubblicato online: 14 apr 2016

Pagine: 9 - 14

Ricevuto: 21 apr 2015

Accettato: 06 lug 2015

DOI: https://doi.org/10.1515/sjecr-2015-0036

Parole chiave

chronic hepatitis C, pegylated interferon alpha 2a, ribavirin, anaemia, thrombocytopenia, leucopoenia, neutropenia

© 2016

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.